Physician profile
Barry S Handler
NPI 1669471892
$2,489.63
in general payments reported to CMS, 2019-2025
17 companies · $984 in 2025
The $984 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $18.61 · 2021: $57.05 · 2022: $160 · 2023: $496 · 2024: $644 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,880 · Long Term Medical Supply Or Device Loan: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.90 |
| Long Term Medical Supply Or Device Loan | $244.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $427.88 | 2021-2023 | Tepezza |
| Tela Bio, INC. | $293.71 | 2021-2024 | Ovitex 2s |
| Amgen INC. | $292.10 | 2024-2025 | Tepezza |
| Integra Lifesciences Corporation | $269.06 | 2022-2025 | Micromatrix |
| Merz North America, INC. | $209.86 | 2023 | |
| Abbvie INC. | $166.08 | 2024-2025 | |
| Kls-Martin L.P. | $158.87 | 2024 | |
| Axogen | $137.65 | 2025 | |
| Mentor Worldwide LLC | $136.92 | 2025 | Artoura Breast Tissue Expander |
| Galderma Laboratories, L.P. | $132.94 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $103.38 | 2025 | |
| Becton, Dickinson and Company | $97.22 | 2025 | Phasix Mesh |
| Vertex Pharmaceuticals Incorporated | $19.32 | 2024 | |
| Apyx Medical Corporation | $18.61 | 2020 | |
| Acera Surgical, INC. | $13.96 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $12.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Handler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.